Seattle, WA – March 6, 2025
SeaBridge, a new program advancing cell and genome reprogramming technologies at the Seattle Hub for Synthetic Biology, has received a $10 million, five-year grant from the Washington Research Foundation (WRF)—one of the largest in WRF’s history.
Led by Drs. Jay Shendure, Marion Pepper, and Jesse Gray, SeaBridge will train 40 postdoctoral fellows to drive next-generation cell therapies and launch new biotech startups addressing diseases like cancer and neurological and immune disorders. Fellows will work at UW and other Washington-based institutions.
Building on technologies like DNA Typewriter and ENGRAM, SeaBridge bridges foundational synthetic biology research with real-world clinical applications. The program is supported by BBI, the Allen Institute, UW Medicine, CZI, and now WRF through its inaugural BioInnovation Grant.
With this support, SeaBridge aims to position Seattle as a global leader in synthetic biology and transform how we understand and treat disease.
Read more about the award here.